Givaudan announced Novaberin, a patent-pending botanical ingredient designed to support metabolic health. Metabolic health refers to how effectively our bodies regulate energy, process nutrients and maintain homeostasis. In a six-month clinical study on Novaberin involving adults seeking support for healthy metabolic function, key outcomes included support for healthy weight management and retaining healthy blood glucose and lipid levels. Formulated from Barberry (Berberis aristata), a natural source of berberine, and Amla fruit (Phyllanthus emblica), Novaberin delivers a multi-benefit approach in a convenient daily dose of 2 x 250 mg.
As the longevity market evolves, consumers are increasingly viewing metabolic health as a foundation for lifelong wellbeing. Today, 40 per cent actively use products to support cardiovascular health, metabolic health, and weight management. “Consumers are increasingly looking for solutions that go beyond weight management alone and support broader metabolic health goals,” said Timothée Olagne, Head of Marketing, Health & Functional Business Unit. “Novaberin offers a clinically researched botanical that mirrors the convenience consumers increasingly expect, while supporting three areas of metabolic health.”
Novaberin begins with responsibly sourced botanicals from India. The ingredient comes with full traceability and identity documentation to support authenticity and quality assurance. Its carefully monitored origins help build trust in a growing market that is increasingly affected by adulteration concerns.
